243 related articles for article (PubMed ID: 35488257)
1. Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls.
Koopaie M; Ghafourian M; Manifar S; Younespour S; Davoudi M; Kolahdooz S; Shirkhoda M
BMC Cancer; 2022 Apr; 22(1):473. PubMed ID: 35488257
[TBL] [Abstract][Full Text] [Related]
2. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection.
Xiao H; Zhang Y; Kim Y; Kim S; Kim JJ; Kim KM; Yoshizawa J; Fan LY; Cao CX; Wong DT
Sci Rep; 2016 Feb; 6():22165. PubMed ID: 26911362
[TBL] [Abstract][Full Text] [Related]
3. Salivary cystatin S levels in children with early childhood caries in comparison with caries-free children; statistical analysis and machine learning.
Koopaie M; Salamati M; Montazeri R; Davoudi M; Kolahdooz S
BMC Oral Health; 2021 Dec; 21(1):650. PubMed ID: 34922509
[TBL] [Abstract][Full Text] [Related]
4. Reg3A (regenerating family member 3 alpha) acts as a tumor suppressor by targeting DMBT1 (deleted in malignant brain tumors 1) in gastric cancer.
Wang L; Tuo H; Song Z; Li W; Peng Y
Bioengineered; 2021 Dec; 12(1):7644-7655. PubMed ID: 34605357
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis.
Unić A; Derek L; Duvnjak M; Patrlj L; Rakić M; Kujundžić M; Renjić V; Štoković N; Dinjar P; Jukic A; Grgurević I
Ann Clin Biochem; 2018 May; 55(3):355-362. PubMed ID: 28766361
[TBL] [Abstract][Full Text] [Related]
6. Assessment of salivary miRNA, clinical, and demographic characterization in colorectal cancer diagnosis.
Koopaie M; Manifar S; Talebi MM; Kolahdooz S; Razavi AE; Davoudi M; Pourshahidi S
Transl Oncol; 2024 Mar; 41():101880. PubMed ID: 38262109
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW
Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497
[TBL] [Abstract][Full Text] [Related]
8. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
9. The Role of NMP22 and CSTB Levels in Predicting Postoperative Recurrence of Bladder Cancer.
Huang C; Ai X; Hu L; Ren D
J Immunol Res; 2022; 2022():6735310. PubMed ID: 35647202
[TBL] [Abstract][Full Text] [Related]
10. Salivary
Chen WD; Zhang X; Zhang MJ; Zhang YP; Shang ZQ; Xin YW; Zhang Y
World J Gastroenterol; 2022 Aug; 28(30):4120-4132. PubMed ID: 36157109
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Localization of Deleted in Malignant Brain Tumors 1 in Normal Human Tissues.
Bathum Nexoe A; Pedersen AA; von Huth S; Detlefsen S; Hansen PL; Holmskov U
J Histochem Cytochem; 2020 Jun; 68(6):377-387. PubMed ID: 32436776
[TBL] [Abstract][Full Text] [Related]
12. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer.
Shu J; Yu H; Li X; Zhang D; Liu X; Du H; Zhang J; Yang Z; Xie H; Li Z
Oncotarget; 2017 May; 8(22):35718-35727. PubMed ID: 28415698
[TBL] [Abstract][Full Text] [Related]
13. Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
Park HS; Kim BC; Yeo HY; Kim KH; Yoo BC; Park JW; Chang HJ
Oncol Rep; 2018 May; 39(5):2279-2287. PubMed ID: 29498404
[TBL] [Abstract][Full Text] [Related]
14. DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN.
Sheng S; Jiwen W; Dexiang Z; Bohao Z; Yueqi W; Han L; Xiaoling N; Tao S; Liu H
Biosci Biotechnol Biochem; 2019 Dec; 83(12):2257-2264. PubMed ID: 31411121
[TBL] [Abstract][Full Text] [Related]
15. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway.
Ma N; Zhao Y
Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818
[TBL] [Abstract][Full Text] [Related]
16. Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer.
Kang W; Nielsen O; Fenger C; Leslie G; Holmskov U; Reid KB
Carcinogenesis; 2005 Jun; 26(6):1129-37. PubMed ID: 15760920
[TBL] [Abstract][Full Text] [Related]
17. DMBT1 inhibition of Pseudomonas aeruginosa twitching motility involves its N-glycosylation and cannot be conferred by the Scavenger Receptor Cysteine-Rich bacteria-binding peptide domain.
Li J; Wan SJ; Metruccio MME; Ma S; Nazmi K; Bikker FJ; Evans DJ; Fleiszig SMJ
Sci Rep; 2019 Sep; 9(1):13146. PubMed ID: 31511582
[TBL] [Abstract][Full Text] [Related]
18. The protective role of DMBT1 in cervical squamous cell carcinoma.
Zhang CX
Kaohsiung J Med Sci; 2019 Dec; 35(12):739-749. PubMed ID: 31400059
[TBL] [Abstract][Full Text] [Related]
19. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
20. DMBT1 has a protective effect on allergic rhinitis.
Zhao Y; Tao Q; Wu J; Liu H
Biomed Pharmacother; 2020 Jan; 121():109675. PubMed ID: 31810134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
